E Zorio

Summary

Publications

  1. ncbi request reprint Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets
    E Zorio
    Cardiology Department, Hospital Universitario La Fe, Av Campanar 21, Valencia, Spain
    Cardiovasc Hematol Agents Med Chem 7:82-90. 2009
  2. ncbi request reprint Induction therapy with daclizumab in heart transplantation--how many doses?
    V Ortiz
    Heart Failure and Transplant Unit, Cardiology Department, La Fe University Hospital, Valencia, Spain
    Transplant Proc 38:2541-3. 2006
  3. ncbi request reprint Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen
    J Aguero
    Heart Failure and Transplantation Unit, Cardiology Service, Universitary Hospital La Fe, Valencia, Spain
    Transplant Proc 38:2558-9. 2006
  4. ncbi request reprint Influence of immunosuppression regimen on heart transplantation survival
    J Aguero
    Heart Failure and Transplantation Unit, Cardiology Service, University Hospital La Fe, Valencia, Spain
    Transplant Proc 38:2550-2. 2006
  5. ncbi request reprint Evolutional changes in maintenance immunosuppression following heart transplantation
    I Sánchez-Lázaro
    Heart Failure and Transplantation Unit, Hospital Universitario La Fe, Valencia, Spain
    Transplant Proc 38:2553-4. 2006
  6. ncbi request reprint Does amiodarone influence early mortality in heart transplantation?
    I J Sánchez-Lázaro
    Cardiology Department, La Fe University Hospital, Valencia, Spain
    Transplant Proc 38:2537-8. 2006
  7. ncbi request reprint Influence of induction therapy on rejection and survival in heart transplantation
    L Almenar
    Department of Cardiology, La Fe University Hospital, Valencia, Spain
    Transplant Proc 37:4024-7. 2005
  8. ncbi request reprint Is there a correlation between brain naturietic peptide levels and echocardiographic and hemodynamic parameters in heart transplant patients?
    L Almenar
    Department of Cardiology, La Fe University Hospital, Valencia, Spain
    Transplant Proc 38:2534-6. 2006
  9. ncbi request reprint Role of microRNAs in gynecological pathology
    J Gilabert-Estelles
    Gynecology Service, Hospital Universitario Dr Peset, Valencia, Spain
    Curr Med Chem 19:2406-13. 2012
  10. ncbi request reprint Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions
    E Zorio
    Department of Cardiology, Hospital Universitario La Fe, Centro de Investigacion, Av Campanar 21, 46009 Valencia, Spain
    J Thromb Haemost 4:1530-6. 2006

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets
    E Zorio
    Cardiology Department, Hospital Universitario La Fe, Av Campanar 21, Valencia, Spain
    Cardiovasc Hematol Agents Med Chem 7:82-90. 2009
    ..However, the final effect of the blockage of microRNAs in vivo remains unclear, since each of them can target hundreds of genes with different intensity. The era of the microRNAs in cardiovascular diseases has just started...
  2. ncbi request reprint Induction therapy with daclizumab in heart transplantation--how many doses?
    V Ortiz
    Heart Failure and Transplant Unit, Cardiology Department, La Fe University Hospital, Valencia, Spain
    Transplant Proc 38:2541-3. 2006
    ..Their benefits versus OKT3 appear evident, although the optimal dose remains to be established. Our objective was to establish possible differences related to the use of two versus five doses of daclizumab...
  3. ncbi request reprint Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen
    J Aguero
    Heart Failure and Transplantation Unit, Cardiology Service, Universitary Hospital La Fe, Valencia, Spain
    Transplant Proc 38:2558-9. 2006
    ..To evaluate the frequency of infection according to the immunosuppressive regimens used in our center...
  4. ncbi request reprint Influence of immunosuppression regimen on heart transplantation survival
    J Aguero
    Heart Failure and Transplantation Unit, Cardiology Service, University Hospital La Fe, Valencia, Spain
    Transplant Proc 38:2550-2. 2006
    ..To perform an analysis comparing long-term survival in heart transplant (HT) patients depending on the immunosuppressive regimen...
  5. ncbi request reprint Evolutional changes in maintenance immunosuppression following heart transplantation
    I Sánchez-Lázaro
    Heart Failure and Transplantation Unit, Hospital Universitario La Fe, Valencia, Spain
    Transplant Proc 38:2553-4. 2006
    ..Patients with a heart transplant (HT) may require changes in their immunosuppressive maintenance medication. The basic treatment regimen in our patients consisted of an anticalcineurin agent, an antimetabolite, and a steroid...
  6. ncbi request reprint Does amiodarone influence early mortality in heart transplantation?
    I J Sánchez-Lázaro
    Cardiology Department, La Fe University Hospital, Valencia, Spain
    Transplant Proc 38:2537-8. 2006
    ..The multivariate analysis did not reveal any variable that correlated with early mortality. Our study did not support the idea that amiodarone constituted a negative predictor of early survival or acute graft failure...
  7. ncbi request reprint Influence of induction therapy on rejection and survival in heart transplantation
    L Almenar
    Department of Cardiology, La Fe University Hospital, Valencia, Spain
    Transplant Proc 37:4024-7. 2005
    ..The objective of this study was to determine whether the use of IL-2 receptor antagonists in induction therapy has implications for the development of rejection and survival...
  8. ncbi request reprint Is there a correlation between brain naturietic peptide levels and echocardiographic and hemodynamic parameters in heart transplant patients?
    L Almenar
    Department of Cardiology, La Fe University Hospital, Valencia, Spain
    Transplant Proc 38:2534-6. 2006
    ..We sought to determine whether BNP values were correlated with echocardiographic and hemodynamic parameters among a large cohort of heart transplant patients...
  9. ncbi request reprint Role of microRNAs in gynecological pathology
    J Gilabert-Estelles
    Gynecology Service, Hospital Universitario Dr Peset, Valencia, Spain
    Curr Med Chem 19:2406-13. 2012
    ..The development of therapies that might block the expression or mimic the functions of miRNAs could represent new therapeutic strategies for any of the aforementioned gynecological disorders...
  10. ncbi request reprint Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions
    E Zorio
    Department of Cardiology, Hospital Universitario La Fe, Centro de Investigacion, Av Campanar 21, 46009 Valencia, Spain
    J Thromb Haemost 4:1530-6. 2006
    ..As activated protein C (APC) provides systemic anticoagulant and anti-inflammatory protection, a low plasma APC level may be an arterial thrombotic risk factor...
  11. ncbi request reprint Risk factors affecting survival in heart transplant patients
    L Almenar
    Department of Cardiology, La Fe University Hospital, Valencia, Spain
    Transplant Proc 37:4011-3. 2005
    ..The objective of this study was to determine whether the risk factors usually available prior to HT result in an excess mortality in our setting that contraindicates transplantation...